Sign inJoin waitlistJoin the waitlist

AG

Armin Ghobadi

Clinical Co-Leader) · Alvin J. Siteman Cancer Center

Credentials: · ·

History

Alvin J. Siteman Cancer Center
Present
Washington University/B-JH/SLCH Consortium
Present

Hematology and Medical Oncology
Washington University/B-JH/SLCH Consortium
2014–2017
Bone Marrow Transplantation
University of Texas M D Anderson Cancer Center
2011–2014
Internal Medicine
University of Texas Southwestern Medical Center
2008–2011
Radiology-Diagnostic
Washington University/B-JH/SLCH Consortium
2004–2008
Preliminary or Transitional Year
2003–2004
Iran University of Medical Sciences
1999–2003

Research

Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
New England Journal of Medicine · 2017 · 4,914 citations
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
Review · Biology of Blood and Marrow Transplantation · 2019 · 3,048 citations
Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1-2 trial
The Lancet Oncology · 2019 · 1,921 citations

John DiPersio
36 papers
FL
Frederick Locke
24 papers
Keith Stockerl-Goldstein
21 papers
YL
Yi Lin
20 papers
David Miklos
19 papers
Ravi Vij
19 papers
Amanda Cashen
18 papers
Caron Jacobsen
18 papers
Olalekan Oluwole
18 papers
PW
Peter Westervelt
18 papers
Mark Schroeder
17 papers
Geoffrey Uy
15 papers

Clinical trials

Safety and Efficacy of CS1 CAR-T (WS-CART-CS1) in Subjects With Multiple Myeloma
Principal investigator · Recruiting · Phase 1
Washington University School of Medicine
2024–2040
Mosunetuzumab Consolidation Therapy After autoSCT in r/r Aggressive B Cell Lymphoma
Principal investigator · Active not recruiting · Phase 1
Washington University School of Medicine
2022–2028
Duvelisib Following Chimeric Antigen Receptor T-Cell Therapy
Principal investigator · Active not recruiting · Phase 1
Washington University School of Medicine
2022–2030
Serum Neurofilament Light (NfL) as a Marker for Brain Injury in Individuals Undergoing Chimeric Antigen Receptor-modified T Therapy
Principal investigator · Terminated
Washington University School of Medicine
2021–2023